Webinar
MIDAS Early Bird: A perspective on how 2022 began defining the new normal
calendar

March 9, 2023

Calendar
clock

2:30pm - 3:30pm

(GMT+01:00)

Register

View all IQVIA events

Join the MIDAS Early Bird Webinar on "A perspective on how 2022 began defining the new normal" to get a first view of key pharma metrics throughout 2022, and a look at the growth areas and emerging trends.

As the world continues to change, the pharmaceutical industry must navigate the powerful forces shaping the future of healthcare. With changes happening at every level of the supply chain, from manufacturing to physician and patient behaviour, understanding these shifts is more crucial than ever.

As we take a retrospective look at 2022, we're eager to uncover the growth areas and emerging trends that will shape the pharmaceutical market in the coming years. Join us as we explore the new normal in the pharmaceutical industry and discover what the future holds.

Register now!

SPEAKER:

Aurelio Arias

Thought Leadership Director, IQVIA

Aurelio creates topical and forward-looking strategic content relevant to pharma executives worldwide and publishes articles, blogs and white papers on a regular basis.

Aurelio’s predominant focus is on off-patent markets where he generates evidence-led insights with a view to spark high-level discourse on biosimilars, generics and value added medicines. Moreover, he is involved in numerous projects exploring the interface between healthcare and digital technology.

He is considered a subject matter expert in these areas and speaks at numerous conferences worldwide, presents at board-level meetings and engages in consulting projects.

Prior to IQVIA, Aurelio has worked in Discovery R&D and as a strategy consultant in Life Sciences. He holds an MSci in Chemistry from Imperial College London.

Contact Us